Glomerular Disease
Genetic testing informs real-world kidney care decisions
SAN DIEGO — Genetic evaluation of patients referred to a U.S. glomerular disease center revealed a genetic diagnosis in 35% of cases, informing prognosis and treatment and allowing for family testing, among other benefits.
FDA grants rare pediatric disease designation to zaltenibart for C3 glomerulopathy
The FDA has granted rare pediatric disease designation to Omeros Corporation’s zaltenibart for the treatment of complement 3 glomerulopathy, according to a press release.
VIDEO: Patients face many challenges after glomerular disease diagnosis
In these videos, Koyal Jain, MD, MPH, FASN, associate professor of medicine and director, nephrology and hypertension training program at UNC School of Medicin, discusses the latest advancements in glomerular diseases.
Rate of kidney replacement therapy for primary glomerular disease varies by country
Rate of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease varies between European countries and was highest for immunoglobulin A nephropathy and focal segmental glomerulosclerosis, study data show.
Cardiovascular, thromboembolic events more closely tied to kidney vs. glomerular disease
Incident cardiovascular and thromboembolic events may be more closely linked to the severity of kidney disease than with glomerular disease subtype, according to results of a prospective study.
New research, treatments move glomerular disease to center of nephrology care
Treatment of glomerular disease has a hard endpoint, Brad H. Rovin, MD, FACP, FASN, said — slowing progression of chronic kidney disease by stabilizing or improving eGFR.
Improvements in training for glomerular diseases can attract more fellows to nephrology
In April 2022, the American Society of Nephrology established an expert task force to examine training requirements in nephrology.
Study: Higher medication nonadherence for Black vs. white adults with glomerular disease
PHILADELPHIA — Black adults with glomerular diseases showed more medication nonadherence compared with white adults, according to study results presented at ASN Kidney Week, here.
VIDEO: Upcoming studies on treatments showing potential in glomerular diseases
VIDEO: Glomerular diseases treatment space 'booming'
In these videos, Koyal Jain, MD, MPH, FASN, associate professor of medicine and director, nephrology and hypertension training program at UNC School of Medicin, discusses the latest advancements in glomerular diseases.